Status:
RECRUITING
Bidirectional Cohort Study of Nanfang Spondyloarthritis
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Southern Medical University, China
Conditions:
Spondyloarthritis (SpA)
Ankylosing Spondylitis (AS)
Eligibility:
All Genders
10-59 years
Brief Summary
Spondyloarthritis（SpA） patients attending Nanfang Hospital of Southern Medical University will generate a large number of clinical condition scales, laboratory indicators, imaging data such as X-rays ...
Detailed Description
In this study, on the basis of not imposing randomized or interventional treatments and not generating additional examination tests on patients, the chronic disease data formed by multiple visits of S...
Eligibility Criteria
Inclusion
- Attended Nanfang Hospital, Southern Medical University, 2010-2030 2.Prospective cohort study component: subjects voluntarily participate with informed consent and sign an informed consent form 3.Retrospective cohort study: (i) patients who visited the hospital from April 2010 to April 2024 (and who will not return to the hospital at a later date) were exempted from informed consent; (ii) patients who visited the hospital from May 2024 to April 2025 were required to sign an informed consent 4.10 years old ≤ age ≤ 59 years old 5.Patients with a standardized diagnosis of spondyloarthritis by the following guidelines or diagnostic criteria, i.e., meeting one of the following diagnostic criteria: (1) 2009 ASAS classification criteria for axial spondyloarthritis; (2) 2011 ASAS classification criteria for peripheral spondyloarthritis
Exclusion
- 1\. Women who are pregnant, preparing for pregnancy or breastfeeding 2.Moderate to Severe Heart Failure (New York Heart Association Class 3-4) 3.Active peptic ulcers/bleeding 4.Judged by the investigator to be unsuitable for participation in this study
Key Trial Info
Start Date :
May 17 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06988813
Start Date
May 17 2025
End Date
April 30 2030
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hostipal,Southern Medical University
Guangzhou, Guangdong, China, 510515